Latest Insider Transactions at Personalis, Inc. (PSNL)
This section provides a real-time view of insider transactions for Personalis, Inc. (PSNL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Personalis, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Personalis, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,446
-1.44%
|
$63,596
$26.73 P/Share
|
|
Mar 17
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,130
-1.34%
|
$29,380
$26.73 P/Share
|
|
Mar 06
2021
|
Woodrow A Myers Jr |
BUY
Grant, award, or other acquisition
|
Direct |
2,610
+50.0%
|
-
|
|
Mar 02
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
345
-0.41%
|
$11,040
$32.6 P/Share
|
|
Mar 02
2021
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,022
-1.74%
|
$96,704
$32.6 P/Share
|
|
Feb 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
40,000
-9.73%
|
$1,520,000
$38.49 P/Share
|
|
Feb 01
2021
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
13,422
+12.02%
|
$0
$0.44 P/Share
|
|
Dec 17
2020
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,391
-1.36%
|
$86,076
$36.37 P/Share
|
|
Dec 17
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
1,087
-0.97%
|
$39,132
$36.37 P/Share
|
|
Dec 02
2020
|
Aaron Tachibana CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,926
-1.64%
|
$79,002
$27.76 P/Share
|
|
Dec 02
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
293
-0.26%
|
$7,911
$27.76 P/Share
|
|
Dec 01
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
40,000
-13.97%
|
$1,080,000
$27.95 P/Share
|
|
Dec 01
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+20.75%
|
$0
$0.44 P/Share
|
|
Oct 20
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
130,486
-3.36%
|
$3,523,122
$27.66 P/Share
|
|
Oct 19
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
196,423
-4.81%
|
$5,303,421
$27.86 P/Share
|
|
Oct 16
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
94,218
-2.26%
|
$2,449,668
$26.68 P/Share
|
|
Oct 15
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
3,700
-0.09%
|
$96,200
$26.32 P/Share
|
|
Oct 14
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
81,925
-1.92%
|
$2,211,975
$27.08 P/Share
|
|
Oct 13
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
86,819
-2.0%
|
$2,430,932
$28.43 P/Share
|
|
Oct 12
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
115,541
-2.59%
|
$3,350,689
$29.09 P/Share
|
|
Oct 01
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct |
40,000
-13.93%
|
$840,000
$21.97 P/Share
|
|
Oct 01
2020
|
Richard Chen CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
37,452
+19.69%
|
$0
$0.44 P/Share
|
|
Aug 18
2020
|
Abingworth LLP |
SELL
Open market or private sale
|
Indirect |
986,842
-18.11%
|
$18,749,998
$19.0 P/Share
|
|
Jun 24
2019
|
Abingworth LLP |
BUY
Conversion of derivative security
|
Indirect |
5,260,651
+31.02%
|
-
|